Results 141 to 150 of about 115,097 (264)

The economic burden of rheumatic heart disease in the Eastern Mediterranean Region. [PDF]

BMJ Glob Health
Elmusharaf K, Poix S, Scaria EB, Saherwala M, Byström M, Hammerich A, Mohamud AK, El Berri H, Hag E.   +8 more
europepmc   +1 more source

DOUBLE VALVULOPLASTY DONE IN A YOUNG PATIENT WITH CHRONIC RHEUMATIC HEART DISEASE

Ananya Buddharaju, Sadanand Reddy Tummala, Vennela Sai Tiruveedhi   +2 more
openalex   +1 more source

Features of heritable disorders of connective tissue in children with acute rheumatic fever and rheumatic heart disease [PDF]

, 2020
Oksana Boyarchuk
openalex   +1 more source

Defining Optimally Safe and Effective Blood Levels of Hydroxychloroquine in Lupus: An Important Step toward Precision Drug Monitoring

Arthritis &Rheumatology, Accepted Article.
Background Using hydroxychloroquine (HCQ) dose of 5 mg/kg/day in systemic lupus erythematosus (SLE) is associated with a higher risk of flares; HCQ blood level monitoring could be a better way to adjust HCQ dose. We studied the upper threshold for a reference range of HCQ levels to inform routine monitoring.
Shivani Garg, Benoît Blanchet, Yann Nguyen, Fauzia Hollnagel, Ada Clarke, Michelle Petri, Murray B. Urowitz, John G. Hanly, Caroline Gordon, Sang‐Cheol Bae, Juanita Romero‐Diaz, Jorge Sanchez‐Guerrero, Ann E. Clarke, Sasha Bernatsky, Daniel J. Wallace, David A. Isenberg, Anisur Rahman, Joan T. Merrill, Paul R. Fortin, Dafna D. Gladman, Ian N. Bruce, Ellen M. Ginzler, Mary Anne Dooley, Rosalind Ramsey‐Goldman, Susan Manzi, Andreas Jönsen, Graciela S. Alarcón, Ronald F. Van Vollenhoven, Cynthia Aranow, Véronique Le Guern, Meggan Mackay, Guillermo Ruiz‐Irastorza, S. Sam Lim, Murat Inanc, Kenneth C. Kalunian, Søren Jacobsen, Christine A. Peschken, Diane L. Kamen, Anca Askanase, Jill Buyon, Julie Chezel, Alicja Puszkiel, Nathalie Costedoat‐Chalumeau   +42 more
wiley   +1 more source

Community co-design of contextually relevant rheumatic heart disease primary prevention. [PDF]

BMJ Glob Health
Miller M, Vaughn LM, Nakitto M, Pulle J, Sarnacki R, de Loizaga S, Beaton A, Rwebembera J.   +7 more
europepmc   +1 more source

Plasma Proteomics Identifies TAOK3 as a Potential Biomarker of Rheumatoid Arthritis Activity and a Novel Therapeutic Target

Arthritis &Rheumatology, Accepted Article.
Objective Bone destruction associated with active rheumatoid arthritis (RA) remains a major therapeutic challenge, with a lack of reliable molecular markers reflecting bone injury. This study aims to identify novel biomarkers linked to bone destruction in active RA through proteomic analysis, providing new strategies for precise monitoring and targeted
Pengfei Xin, Wenzhen Li, Xinyu A, Jun Shen, Xiaohui Meng, Yanqin Bian, Haihui Han, Zheng Xiang, Lei Ran, Songtao Sun, Jun Xie, Tao Yue, Qi Zhu, Xiaoming Zhang, Lu Xie, Lianbo Xiao   +15 more
wiley   +1 more source

AASLD practice guidance on drug, herbal, and dietary supplement–induced liver injury

, 2022
Hepatology, EarlyView.
Robert J. Fontana, Iris Liou, Adrian Reuben, Ayako Suzuki, M. Isabel Fiel, William Lee, Victor Navarro   +6 more
wiley   +1 more source

Molecular stratification of antiphospholipid syndrome through integrative analysis of the whole‐blood RNA transcriptome

Arthritis &Rheumatology, Accepted Article.
Objective Antiphospholipid syndrome (APS) is a thrombo‐inflammatory disorder characterized by clinical and mechanistic heterogeneity that complicates early diagnosis and hinders targeted treatment. We aimed to identify distinct molecular endotypes among antiphospholipid antibody (aPL)‐positive patients using whole‐blood transcriptomics.
Amala Ambati, Feiyang Ma, Katarina Kmetova, Sherwin Navaz, Claire K. Hoy, Cyrus Sarosh, Ajay Tambralli, Erika Navarro‐Mendoza, Johann E. Gudjonsson, J. Michelle Kahlenberg, Jacqueline A. Madison, Alí Duarte‐García, Jason S. Knight, Yu Zuo   +13 more
wiley   +1 more source

Rheumatic Heart Disease Education Tools Integrated Into a Screening Program in Brazil: Acceptability and Knowledge Gain. [PDF]

Glob Heart
Abrams J, Vinhal WC, Sable CA, Cardoso CS, Zühlke L, Spaziani A, Ryklief L, Nunes MCP, Ribeiro IKS, Previero R, Silva LR, Chavez LMT, Oliveira KKB, Amaral IB, Lemos L, Correa JS, Coelho CT, Santos BA, de Paula LH, Souza IS, Santiago MLBS, Freitas BC, Angelo GR, Nunes MHP, Pereira KJ, Ribeiro ALP, Nascimento BR, PROVAR+ (Programa de RastreamentO da VAlvopatia Reumática and Other Cardiovascular Diseases) investigators.   +27 more
europepmc   +1 more source

Table 2_Changes in the burden and underlying causes of rheumatic heart disease in children and youths, 1990–2021: an analysis of the Global Burden of Disease Study 2021.docx

Chang Li (133800), Liuming Gao (21604394), Yanggan Wang (6013952)   +2 more
openalex   +1 more source